CDK9-IN-2

Supplier MedChemExpress
Product # HY-16462-50 mg
CAS # 1263369-28-3
Pricing 50 mg, USD $960.0
Biological Activity CDK9-IN-2 is a special cyclin-dependent kinase 9 (CDK9) inhibitor, extracted from patent WO/2012131594A1, compound CDKI(8), has an IC50 of 5 nM and 7 nM in H929 multiple myeloma(MM) cell line (72 hours) and A2058 skin cell line (72 hours), respectively.
Purity 99.84%
MWt 425.93
Formula C₂₃H₂₅ClFN₅
Feedback